Substantia Nigra Hyperechogenicity as a Marker for Parkinson's Disease: A Population-Based Study
暂无分享,去创建一个
Klaus Seppi | Philipp Mahlknecht | Werner Poewe | Christoph Scherfler | Johann Willeit | W. Poewe | S. Kiechl | J. Willeit | P. Mahlknecht | C. Scherfler | K. Seppi | G. Rungger | Arno Gasperi | M. Nocker | Arno Gasperi | Stefan Kiechl | Heike Stockner | Gregorio Rungger | Michael Nocker | Christoph Schmidauer | H. Stockner | C. Schmidauer | A. Gasperi
[1] G Becker,et al. Relationship of substantia nigra echogenicity and motor function in elderly subjects , 2001, Neurology.
[2] S. Fahn. Description of Parkinson's Disease as a Clinical Syndrome , 2003, Annals of the New York Academy of Sciences.
[3] Matthias Reimold,et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study , 2008, The Lancet Neurology.
[4] Y Ben-Shlomo,et al. Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London , 2000, BMJ : British Medical Journal.
[5] R. Benecke,et al. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[6] Werner Poewe,et al. Midbrain sonography in patients with essential tremor , 2007, Movement disorders : official journal of the Movement Disorder Society.
[7] W. Poewe,et al. A follow‐up study of substantia nigra echogenicity in healthy adults , 2012, Movement disorders : official journal of the Movement Disorder Society.
[8] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[9] J. Jeng,et al. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[10] Uwe Walter,et al. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. , 2007, Archives of neurology.
[11] W. Poewe,et al. Prevalence of movement disorders in men and women aged 50–89 years (Bruneck Study cohort): a population-based study , 2005, The Lancet Neurology.
[12] Klaus Fassbender,et al. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. , 2006, Brain : a journal of neurology.
[13] U. Dillmann,et al. Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly , 2010, Movement disorders : official journal of the Movement Disorder Society.
[14] Uwe Walter,et al. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. , 2007, Brain : a journal of neurology.
[15] Stephen R. Duma,et al. Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing , 2007, NeuroImage.
[16] Daniela Berg,et al. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings , 2001, Journal of Neurology.
[17] R. Hilker,et al. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[18] R. Benecke,et al. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease , 2002, Journal of Neural Transmission.
[19] Yoav Ben-Shlomo,et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.
[20] J. A. Cook,et al. Heterogeneity in male to female risk for Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery & Psychiatry.
[21] Andrew J. Lees,et al. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease , 2001, Neurology.
[22] Daniela Berg,et al. Five‐year follow‐up study of hyperechogenicity of the substantia nigra in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[23] Klaus Fassbender,et al. Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[24] J. Fleiss,et al. Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.
[25] D. Dressler,et al. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[26] W. Poewe,et al. Defining at‐risk populations for Parkinson's disease: Lessons from ongoing studies , 2012, Movement disorders : official journal of the Movement Disorder Society.
[27] Jochen Klenk,et al. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. , 2011, Archives of neurology.
[28] E. Katunina,et al. [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.
[29] D. Dressler,et al. Assessment of Substantia Nigra Echogenicity in German and Filipino Populations Using a Portable Ultrasound System , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[30] A J Lees,et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study , 2001, Neurology.
[31] Klaus Seppi,et al. Neuroimaging: Current role in detecting pre‐motor Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[32] G Becker,et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound , 1999, Neurology.
[33] W. Poewe,et al. Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease? , 2012, Movement disorders : official journal of the Movement Disorder Society.
[34] K. Bötzel,et al. Prevalence and incidence of Parkinson's disease in Europe , 2005, European Neuropsychopharmacology.
[35] D. Berg,et al. In vivo detection of iron and neuromelanin by transcranial sonography – a new approach for early detection of substantia nigra damage , 2006, Journal of Neural Transmission.
[36] D. Schwartz,et al. Toll-like receptor 4 polymorphisms and atherogenesis in humans. , 2002 .
[37] Daniela Berg,et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. , 2002, Archives of neurology.
[38] G. Cooke,et al. Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.
[39] Michal Bar,et al. Transcranial sonography in movement disorders. , 2008, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[40] J. Molinuevo,et al. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder , 2009, Movement disorders : official journal of the Movement Disorder Society.
[41] W. Poewe,et al. Is Transcranial Sonography Useful to Distinguish Drug-Induced Parkinsonism From Parkinson ’ s Disease ? , 2012 .